SELLAS Life Sciences (SLS) Net Margin (2013 - 2022)

SELLAS Life Sciences (SLS) reported Net Margin of 1673.5% for Q1 2022, down 163134.0% year-over-year from N/an in Q1 2021, and down 589.28% on a QoQ basis from 242.79% in Q2 2021.

SELLAS Life Sciences (SLS) has 6 years of Net Margin data on file, last reported at 1673.5% in Q1 2022.

  • Quarterly Net Margin fell 163134.0% year-over-year to 1673.5% in Q1 2022, while the trailing twelve-month figure through Dec 2022 was 4195.0% (down 392264.0% YoY) and the FY2022 annual result came in at 4130.1%, down 385774.0% from the prior year.
  • Net Margin eased to 1673.5% in Q1 2022 per SLS's latest filing, from 242.79% in the prior quarter.
  • Across five years, Net Margin topped out at 42.16% in Q1 2021 and bottomed at 1673.5% in Q1 2022.
  • The 3-year median for Net Margin is 219.18% (2020), against an average of 538.51%.
  • Peak annual rise in Net Margin reached 163134 bps in 2022, while the deepest fall reached 163134 bps in 2022.
  • Tracing SLS's Net Margin over 3 years: stood at 195.58% in 2020, then dropped by 24 bps to 242.79% in 2021, then sank by 589 bps to 1673.5% in 2022.
  • Per Business Quant, the three latest SLS Net Margin figures stand at 1673.5% (Q1 2022), 242.79% (Q2 2021), and 42.16% (Q1 2021).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 0.82%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 34.53%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 20.17%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 17.65%
10 SELLAS Life Sciences 1.61 Bn 1.61 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2022 -1,673.50%
Jun 30, 2021 -242.79%
Mar 31, 2021 -42.16%
Dec 31, 2020 -195.58%
Jun 30, 2015 -64.64%
Mar 31, 2015 -81.13%
Dec 31, 2014 468.08%
Sep 30, 2014 -163.02%
Jun 30, 2014 -698.16%
Mar 31, 2014 -545.28%
Dec 31, 2013 167.48%
Jun 30, 2013 -411.71%
Mar 31, 2013 -427.66%